#10,209 by institutional money · ADR
Chemomab Therapeutics Ltd. (CMMB)
Institutional ownership from Q3 2026 Form 13F filings
$1.27
+10.96% today
Live prices, last trade 10:37 AM ET
- 13F holders
- 17 (+4)
- Held by 13F filers, live
- $513K
- Shares held
- 405,401
- Share of stock outstanding
- 5.0%
- Net buying in Q3 2026
- +$32K
- New positions / sold out
- 7 / 3
Largest holders
17 investors| Investor | Shares | Value, live | % of their portfolio | vs Q2 2026 |
|---|---|---|---|---|
| Citadel Advisors LLC Ken Griffin | 109,763 | $139K | <0.1% | Added +15% |
| Kestra Private Wealth Services, LLC | 77,153 | $98K | <0.1% | Added +25% |
| Ikarian Capital, LLC | 51,793 | $66K | <0.1% | Unchanged |
| Rhumbline Advisers | 30,070 | $38K | <0.1% | Reduced −2% |
| Susquehanna International Group, LLP | 24,408 | $31K | <0.1% | New |
| Philadelphia Investment Partners, LLC | 22,566 | $29K | <0.1% | Added +50% |
| Jane Street Group, LLC | 19,637 | $25K | <0.1% | New |
| StoneX Group Inc. | 18,620 | $24K | <0.1% | New |
| Two Sigma Securities, LLC | 13,669 | $17K | <0.1% | New |
| SmartHarvest Portfolios, LLC | 13,031 | $16K | <0.1% | New |
| Renaissance Technologies LLC | 10,328 | $13K | <0.1% | New |
| GAMMA Investing LLC | 9,181 | $12K | <0.1% | Added +94% |
| BNP Paribas Financial Markets | 3,300 | $4K | <0.1% | Reduced −52% |
| Morgan Stanley | 1,600 | $2K | <0.1% | Reduced −55% |
| Nuveen, LLC | 235 | $297 | <0.1% | New |
| SBI Securities Co., Ltd. | 30 | $38 | <0.1% | Reduced −12% |
| Caitong International Asset Management Co., Ltd | 17 | $22 | <0.1% | Added +113% |